Stay updated with breaking news from Celularity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, a growth of 8.8% from the March 15th total of 4,750,000 shares. Approximately 7.4% of the company’s shares are short sold. Based on […]
Item 1.01 Entry into a Material Definitive Agreement. Registered Direct Offering On April 4, 2023, Celularity Inc, or Celularity, entered into a securities purchase agreement with an institutional... | April 7, 2023
Celularity’s Pre-Request for Designation is based on data demonstrating 100 percent biochemical characterization of the product Celularity intends to submit 510 pre-market notification to the... | April 3, 2023
Celularity Inc. (NASDAQ:CELU – Get Rating) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,750,000 shares, a growth of 38.1% from the February 28th total of 3,440,000 shares. Currently, 9.2% of the company’s shares are sold short. Based on […]
Celularity Inc. (NASDAQ:CELUW – Get Rating) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 8,700 shares, an increase of 19.2% from the February 28th total of 7,300 shares. Based on an average trading volume of 19,300 shares, the short-interest ratio is currently […]